NCT00503412View on ClinicalTrials.gov

Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

May 31, 2006

Conditions

Advanced Solid Metastatic Tumor

Interventions

DRUG

AZD2171

oral 14C

Trial Locations (1)

Unknown

Research Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY